Diagnostics
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
3,300
NCT05735704
Early Detection and Screening of Hematological Malignancies - SANGUINE
Phase: N/A
Role: Lead Sponsor
Start: Jan 30, 2023
Completion: Jan 31, 2026
NCT06963307
Novel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung Cancer
Start: May 31, 2025
Completion: Nov 30, 2026
Loading map...